Triamcinolone spray: No-rub application as effective as rub application

Journal of Cosmetic Dermatology

Volumn 14, Issue 4, 2015, Pages 286-290

  Draelos, Zoe Diana ^a  

^a DERMATOLOGY CONSULTING SERVICES   (United States)

Author keywords

Application technique; Corticosteroid spray; Percutaneous penetration

Indexed keywords

TRIAMCINOLONE ACETONIDE; ANTIINFLAMMATORY AGENT; TRIAMCINOLONE;

ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; ECZEMA; HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN PERMEABILITY; SKIN WATER LOSS; TREATMENT OUTCOME; DERMATITIS, ATOPIC; FEMALE; MALE; MEDICATION COMPLIANCE; METABOLISM; MIDDLE AGED; SINGLE BLIND PROCEDURE; THERMOREGULATION; YOUNG ADULT;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS; DERMATITIS, ATOPIC; ECZEMA; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; SINGLE-BLIND METHOD; TREATMENT OUTCOME; TRIAMCINOLONE; WATER LOSS, INSENSIBLE; YOUNG ADULT;

EID: 84958751840     PISSN: 14732130     EISSN: 14732165     Source Type: Journal    
DOI: 10.1111/jocd.12161     Document Type: Article

References (13)

1. Torrelo A, Ritz J, Alomar A et al. Health-related quality of life, patient satisfaction, and adherence to treatment in patients with moderate or severe atopic dermatitis on maintenance therapy: the CONDA-SAT study. Actas Dermosifiliogr 2013; 104: 409-17.
2. Shergill B, Zokaie S, Carr AJ. Non-adherence to topical treatments for actinic keratosis. Patient Prefer Adherence 2014; 8: 35-41.
3. Brown KK, Rehmus WE, Kimball AB. Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis. J Am Acad Dermatol 2006; 55: 607-13.
4. Devaux S, Castela A, Archier E et al. Adherence to topical treatment in psoriasis: a systemic literature review. J Eur Acad Dermatol Venereol 2012; 26 (Suppl 3): 61-7.
5. Krejci-Manwaring J, McCarty MA, Camacho F et al. Adherence with topical treatment is poor compared with adherence with oral agents: implications for effective clinical use of topical agents. J Am Acad Dermatol 2006; 54 (Suppl): S235-6.
6. Housman TS, Mellen BG, Rapp SR et al. Patients with psoriasis prefer solution and foam vehicles: a quantitative assessment of vehicle preference. Cutis 2002; 70: 327-32.
7. Clobex Spray [package insert]. Fort Worth, TX: Galderma Laboratories, LP; September 2012.
8. Kenalog Spray [package insert]. Jacksonville, FL: Ranbaxy Pharmaceuticals, Inc; July 2013.
9. Fowler J, Fowler L. Physician and patient assessment of triamcinolone acetonide spray for steroid-responsive dermatoses. J Clin Aesthet Dermatol 2010; 3: 27-31.
10. Gou H, Liu Z, Li J et al. Effects of isopropyl palmitate on the skin permeation of drugs. Biol Pharm Bull 2006; 29: 2324-6.
11. Kanikkannan N, Singh M. Skin permeation enhancement effect and skin irritation of saturated fatty alcohols. Inter J Pharm 2002; 248: 219-28.
12. Mohammed D, Hirata K, Hadgraft J et al. Influence of skin penetration enhancers on skin barrier function and skin protease activity. Euro J Pharma Sci 2014; 51: 118-22.
13. Barany E, Lindberg M, Loden M. Unexpected skin barrier influence from nonionic emulsifiers. Int J Pharm 2000; 195: 189-95.